Product Center
Received the clinical approval for a new drug of the first class of biological products
- Categories:Industry news
- Author:
- Origin:
- Time of issue:2017-11-11
- Views:
(Summary description)In 2017, the company used its own patented technology to develop a new class of biological products: the quadrivalent influenza virus subunit vaccine, which was approved by the CFDA for clinical appro
Received the clinical approval for a new drug of the first class of biological products
(Summary description)In 2017, the company used its own patented technology to develop a new class of biological products: the quadrivalent influenza virus subunit vaccine, which was approved by the CFDA for clinical appro
- Categories:Industry news
- Author:
- Origin:
- Time of issue:2017-11-11 10:57
- Views:
In 2017, the company used its own patented technology to develop a new class of biological products: the quadrivalent influenza virus subunit vaccine, which was approved by the CFDA for clinical approval.
Relevant information
-
Ab&B Bio and Yither Bio have both obtained qualification certification!Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio） and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) have been recognized as Jiangsu Province's specialized and innovative small and medium-sized enterprises and national high-tech enterprises, respectively. - The kickoff meeting for clinical research on the immunogenicity and safety of quadrivalent influenza virus subunit vaccine for children with nephrotic syndrome was successfully held 12-25
- Influenza virus subunit vaccine (adjuvant) IND application approved 10-30
- The application for the marketing of trivalent influenza virus subunit vaccine has been accepted! 10-08
- Breaking through bottleneck technology, significant progress has been made in the research and development of new adjuvants 08-26
Have a project？Get a touch!
Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio
Contact
E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
